Lord, Abbett & Co’s Artivion AORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-166,006
Closed -$6.08M 565
2026
Q1
$6.08M Sell
166,006
-418,159
-72% -$16.5M 0.02% 430
2025
Q4
$26.6M Sell
584,165
-86,061
-13% -$3.83M 0.08% 238
2025
Q3
$28.4M Buy
670,226
+295,392
+79% +$11.1M 0.08% 243
2025
Q2
$11.7M Sell
374,834
-27,070
-7% -$733K 0.04% 361
2025
Q1
$9.88M Buy
401,904
+95,202
+31% +$2.64M 0.04% 375
2024
Q4
$8.77M Buy
306,702
+88,902
+41% +$2.47M 0.03% 400
2024
Q3
$5.8M Buy
+217,800
New +$5.66M 0.02% 464

Other funds holding AORT

Lord, Abbett & Co's AORT Position: Q2 2026 in Review

Lord, Abbett & Co sold out of Artivion (AORT) in Q2 2026, closing a stake of 166,006 shares — an estimated $6.08M sold.

Lord, Abbett & Co first reported a position in AORT in Q3 2024 and held it in 7 quarters. The position peaked at $28.4M in Q3 2025. 206 funds tracked by Wall St. Rank hold AORT as of Q2 2026.

  • Lord, Abbett & Co reported no remaining Artivion position as of Q2 2026 after selling out during the quarter.
  • Lord, Abbett & Co sold 166,006 Artivion shares in Q2 2026, an estimated $6.08M.
  • Lord, Abbett & Co first reported a position in Artivion in Q3 2024 and held it in 7 quarters.
  • Lord, Abbett & Co's Artivion position peaked at $28.4M in Q3 2025.
  • 206 funds tracked by Wall St. Rank held Artivion as of Q2 2026.

Based on Lord, Abbett & Co's 13F filing for Q2 2026, filed 14 Aug 2026.